SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: Sergio H who wrote (10144)8/1/2005 7:13:08 PM
From: Galirayo  Read Replies (2) | Respond to of 23958
 
Sergio .. I never heard of SKYPE until the other day ...

I don't want in any Hard Wired Land Line Carriers. Like Baby Bells or RBOCs.

Chart looks good. I think we're more likely to have moves in Commodities and OSXers ... with Alt Energy .. and Especially BioTechs and Pharma Upside Surprises .. on Script Counts.

stockcharts.com[w,a]dacayiay[dc][pb50!c20!f][vc60][iut!Ua12,26,9!Uv25]&pref=G

I made a post back in Feb or so about Bios leading this time. So far so good.

Ray



To: Sergio H who wrote (10144)8/1/2005 9:22:07 PM
From: Galirayo  Read Replies (1) | Respond to of 23958
 
Sergio ... Pick One.

stockcharts.com[w,a]dacayiay[dc][pb50!c20!f][vc60][iut!Ua12,26,9!Uv25]&pref=G

07.15.05, 11:57 AM ET
S&P Equity Research said. Over the next 12 months, the research firm expects sector price appreciation of about 20% and believes the sector could sustain high-teen earnings-per-share growth over the next three years. S&P Equity Research's top recommendations are Genentech (nyse: DNA - news - people ), Amylin Pharmaceuticals (nasdaq: AMLN - news - people ), Renovis (nasdaq: RNVS - news - people ) and Invitrogen (nasdaq: IVGN - news - people ), all rated at "strong buy." The research firm reiterated "strong sell" opinions on Chiron (nasdaq: CHIR - news - forbes.com

What about ARIA ??
stockcharts.com[w,a]dacayiay[dc][pb50!c20!f][vc60][iut!Ua12,26,9!Uv25]&pref=G